The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Karl Chalabala is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/25/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
11/07/2024 | FOLD | Buy Now | Amicus Therapeutics | $7.34 | 186.1% | Karl Chalabala30% | $19 → $21 | Maintains | Buy | Get Alert |
05/10/2024 | FOLD | Buy Now | Amicus Therapeutics | $7.34 | 158.86% | Karl Chalabala30% | $20 → $19 | Maintains | Buy | Get Alert |
09/29/2023 | FOLD | Buy Now | Amicus Therapeutics | $7.34 | 172.48% | Karl Chalabala30% | $19 → $20 | Maintains | Buy | Get Alert |
08/09/2023 | FOLD | Buy Now | Amicus Therapeutics | $7.34 | 158.86% | Karl Chalabala30% | $17 → $19 | Maintains | Buy | Get Alert |
03/02/2023 | FOLD | Buy Now | Amicus Therapeutics | $7.34 | 131.61% | Karl Chalabala30% | $15 → $17 | Maintains | Buy | Get Alert |
02/23/2023 | SCCO | Buy Now | Southern Copper | $94.28 | -45.91% | Karl Chalabala30% | $46.63 → $49.55 | Maintains | Sell | Get Alert |
08/14/2017 | GPOR | Buy Now | Gulfport Energy | $175.00 | -89.71% | Karl Chalabala30% | $21 → $18 | Maintains | Buy | Get Alert |
08/14/2017 | CRK | Buy Now | Comstock Resources | $18.39 | -34.75% | Karl Chalabala30% | $14 → $12 | Maintains | Buy | Get Alert |